When to offer payment to human factors research participants: Some ethical considerations
Written by Andrea Mirin Both in the course of designing studies and as an IRB, questions arise that lead us to contemplate what may be “best practices” or “best ethical practices” for appropriately recruiting participants. One area of frequent discussion, particularly as an IRB, is related to the “honoraria” [1] or “incentives” [2] that are offered. While the amounts offered for a particular participant group are guided by “Fair Market Value,” we should also consider if when the compensation for participation is offered, under ethical principles, may be construed as an “unjust inducement.” Unlike clinical trials (at least later stage clinical trials) which may hold out some potential benefit to a participant, human factors studies (a majority of which are simulated studies), will likely have no direct benefit to the participant (Since frequently user groups are those who may or will use a device, their participation and feedback may influence the...